Form 4 for MRNA Moderna
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001127602-24-007935 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-01 | 2024-02-28 | MRNA | Hoge Stephen | Pres | M - OptEx | — | +4,853 | 1.52M | +0.3% | — |
| D | 2024-03-01 | 2024-02-29 | MRNA | Hoge Stephen | Pres | S - Sale+OE | $94.57 | -2,388 | 1.52M | -0.2% | -$225.8K |
| DM | 2024-03-01 | 2024-02-28 | MRNA | Hoge Stephen | Pres | M - OptEx | $0.00 | -4,853 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | M | A | 2,442 | — | 1,518,286 | D | — | — | (F2) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2024-02-29 | S | D | 2,388 | $94.57 | 1,515,898 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-28 | M | A | 2,411 | — | 1,515,844 | D | — | — | (F2) Restricted stock units convert into common stock on a one-for-one basis. |
| 4 | Derivative | Restricted Stock Units | 2024-02-28 | M | D | 2,442 | $0.00 | 7,326 | D | — · — to — | 2,442 Common Stock | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F5) 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 5 | Derivative | Restricted Stock Units | 2024-02-28 | M | D | 2,411 | $0.00 | 0 | D | — · — to — | 2,411 Common Stock | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F4) 50% of the shares subject to this restricted stock unit award vested on February 28, 2022 with the remainder vesting in eight (8) equal quarterly installments thereafter. |